Mitiglinide (calcium)

CAT:
804-HY-17398-01
Size:
100 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Mitiglinide (calcium) - image 1

Mitiglinide (calcium)

  • Description:

    Mitiglinide Calcium (KAD-1229 anhydrous), an insulinotropic agent, is an ATP-sensitive K+ (KATP) channel antagonist. Mitiglinide Calcium is highly specific to the Kir6.2/SUR1 complex (the pancreatic beta-cell KATP channel) . Mitiglinide Calcium can be used for the research of type 2 diabetes[1][2].
  • Product Name Alternative:

    KAD-1229 (anhydrous) ; S21403 (anhydrous)
  • UNSPSC:

    12352211
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Potassium Channel
  • Type:

    Reference compound
  • Related Pathways:

    Membrane Transporter/Ion Channel
  • Applications:

    Metabolism-protein/nucleotide metabolism
  • Field of Research:

    Metabolic Disease
  • Assay Protocol:

    https://www.medchemexpress.com/Mitiglinide-Calcium.html
  • Purity:

    98.82
  • Solubility:

    DMSO : 5 mg/mL (ultrasonic)
  • Smiles:

    O=C([O-])[C@H](CC(N1C[C@](CCCC2)([H])[C@]2([H])C1)=O)CC3=CC=CC=C3.[0.5Ca2+]
  • Molecular Formula:

    C19H24NO3.1/2Ca
  • Molecular Weight:

    334.44
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]Y Sunaga, et al. The effects of mitiglinide (KAD-1229), a new anti-diabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide. Eur J Pharmacol. 2001 Nov 9;431 (1) :119-25.|[2]Kiyoshi Ichikawa, et al. Effect of KAD-1229, a novel hypoglycaemic agent, on plasma glucose levels after meal load in type 2 diabetic rats. Clin Exp Pharmacol Physiol. May-Jun 2002;29 (5-6) :423-7.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    4°C (Powder, sealed storage, away from moisture)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    Launched
  • CAS Number:

    [145525-41-3]